期刊文献+

Mdm2反义脱氧寡核苷酸抗胶质瘤的机理研究

Anti-cancer effect of antisense Mdm2 oligodeoxynucleotide on human glioma cells
原文传递
导出
摘要 目的探讨Mdm2反义寡核苷酸(ASODNs)对U251人胶质瘤细胞株的抗肿瘤作用。方法以Lipofectamine介导的Mdm2 ASODNs转染U251细胞,用RT-PCR检测Mdm2 mRNA的改变,流式细胞仪检测细胞周期,Western blot检测野生型p53(wild type p53,wtp53)的表达,研究其抗肿瘤作用。结果Mdm2 ASODNs以不同浓度转染U251细胞后,Mdm2表达减少,细胞增殖抑制程度升高,细胞周期分析显示S期细胞下降,TUNEL法染色观察到明显的凋亡细胞。Western blot检测野生型p53的表达增加。结论Mdm2 ASODNs可提高野生型p53的表达,从而抑制U251细胞增殖,引起细胞周期停滞和诱导凋亡,该作用具有浓度依赖性。 Objectives To study the anti-cancer effect of antisense Mdm2 oligodeoxynucleotide on the U251 MG cells. Methods Lipofectamine-mediated antisense Mdm2 ODNs was transfected into U251 MG cells and transfection efficiency was detected by FCM. The expression of Mdm2 mRNA was examined by RT-PCR after ODNs was transfected into cells. MTT assay was used to examine changes in cell proliferation. Apoptosis was evaluated by FCM and TUNEL method, Western blot analysis was used to detect the expression of wild type p53 after ODNs was transfected. Results Mdm2 ODNs were efficiently transfected by Lipofectamine. The expression of Mdm2 mRNA decreased significantly after treatment with antisense ODNs. Antisense ODNs significantly inhibited the proliferation. The cells at S phase decreased in the group treated with antisense ODNs. Apoptosis level and the expression of wild type p53 increased after treated with antisense ODNs. Conclusions Antisense Mdm2 ODNs significantly inhibits the proliferation of U251MG cells and induces their apoptosis in concentration dependent manner.
出处 《中华神经外科杂志》 CSCD 北大核心 2007年第10期787-790,共4页 Chinese Journal of Neurosurgery
基金 湖北省自然科学基金资助项目(2006ABA251)
关键词 神经胶质瘤 MDM2 凋亡 P53 Glioma Mdm2 Apoptosis p53
  • 相关文献

参考文献14

二级参考文献43

  • 1席桂发,陈坚,董震,王代旭,柯超.p53和p16蛋白在星形细胞瘤中的表达及其意义[J].肿瘤防治研究,2004,31(8):474-476. 被引量:2
  • 2林松,王忠诚,张懋植,厉俊华,朱景德,金海英,顾健人.胸苷激酶基因治疗恶性胶质瘤Ⅰ期临床研究[J].中华神经外科杂志,2004,20(5):381-384. 被引量:5
  • 3刘爱学,浦佩玉,程爱国,彭琼,王春艳.人脑胶质瘤P53蛋白表达与p53基因突变的相关性研究[J].中华医学杂志,1996,76(8):605-607. 被引量:3
  • 4刘旭文,浦佩玉,高之宪,李建国,王春艳.神经上皮组织起源的脑肿瘤增殖活性与表皮生长因子受体基因表达的相关性研究[J].中国神经精神疾病杂志,1997,23(3):130-133. 被引量:8
  • 5Barker FG, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiform. Neurosurg,1998, 42: 709-723.
  • 6Ross C, Erickson R. Gene therapy in the United States: a five year status report. Hum Gene Ther, 1996, 7:1781-1790.
  • 7Cool V, Pirotte B, Gerard C, et al. Curative potential of HSV-tk gene transfer in rats with 9L gliosarcoma. Hum Gene Ther, 1996, 7:627 -635.
  • 8Tanaka T, Yamasaki H, Mesnil M. Stimulation of intercellular communication of poor-communicating cells by gap-junctioncompetent cells enhances the HSV-TK/GCV bystander effect in vitro. Int J Cancer, 2001, 91:538-542.
  • 9Klatzmann D, Charles AV, Gilbert B, et al. A Phase Ⅰ/Ⅱ study of HSV-tk "Suicide" gene therapy for recurrent glioblastoma. Hum Gene Ther, 1998, 9:2595-2604.
  • 10Stand N, Weber F, Mariani L, et al. A phase Ⅰ/Ⅱ clinical trial of gene therapy for recurrent glioblastoma multiform by tumor transduction with the HSV-tk gene followed by ganciclovir. Hum Gene Ther, 1999, 10:2325-2335.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部